eViralHepatitis Review

By eViralHepatitis Review

Experts in viral hepatitis review topics in hepatitis C, hepatitis B, and coinfection using patient case scenarios. Certified for CME/CE credit. See acast.com/privacy for privacy and opt-out information.

  1. 1.
    HBV: Next Steps to a Cure
    15:16
  2. 2.
    Treating HCV in PWID: Best Practices
    22:35
  3. 3.
    HCV: Management Beyond the Liver
    21:59
  4. 4.
    Avoiding “MELD Purgatory”
    22:45
  5. 5.
    Clinical Perspectives on Barriers To HBV Care
    24:00
  6. 6.
    Clinical Insight: Engaging PWID in HCV Care
    25:40
  7. 7.
    In the Clinic: Identifying & Managing HCV Complications
    28:09
  8. 8.
    New Options for Patients with “Hard-To-Treat” Hepatitis C Infection
    32:58
  1. 9.
    Using Real World Data to Individualize HCV Management
    33:59
  2. 10.
    Using Real World Data to Individualize HCV Management
    30:00
  3. 11.
    Clinical Insights: HCV and Substance Use Disorder
    24:27
  4. 12.
    Clinical Approaches to HBV Therapy
    32:21
  5. 13.
    HBV: Addressing Current Gaps in Diagnosis and Linkage to Care
    31:50
  6. 14.
    Extrahepatic Manifestations of Hepatitis C: Screening and Management
    31:53
  7. 15.
    Emerging Therapeutic Approaches for Chronic Hepatitis B
    33:23
  8. 16.
    New Approaches to the Diagnosis and Management of Chronic HBV Infection
    30:24
  9. 17.
    Sofosbuvir/Velpatasvir fixed dose combination for 12 Weeks in Patients Co-Infected with HCV and HIV-1: The Phase 3 ASTRAL-5 Study
    16:10
  10. 18.
    Resistance Analysis for Ledipasvir/Sofosbuvir containing regimens in patients infected with chronic HCV who have advanced liver disease or are post Liver Transplant (SOLAR-1 and 2 STUDIES)
    9:43
  11. 19.
    High Efficacy of Sofosbuvir/Velpatasvir plus GS-9857 for 12 Weeks in Treatment-experienced Genotype 1-6 HCV-Infected Patients, Including those Previously Treated with Direct-acting Antivirals
    13:15
  12. 20.
    Hepatitis C Treatment in the HIV Coinfected and Dialysis Populations
    34:43
  13. 21.
    Screening for HCV and HBV Infection in the Clinic
    32:33
  14. 22.
    Advances in Managing Hard-to-Treat Hepatitis C: Highlights from the American Association for the Study of Liver Diseases (AASLD) Meeting November 2015
    12:46
  15. 23.
    Advances in Managing Hard-to-Treat Hepatitis C: Highlights from the American Association for the Study of Liver Diseases (AASLD) Meeting November 2015
    7:19
  16. 24.
    Advances in Managing Hard-to-Treat Hepatitis C: Highlights from the American Association for the Study of Liver Diseases (AASLD) Meeting November 2015
    8:20
  17. 25.
    The New DAAs and HCV Genotype 2/3 Patients
    33:59
  18. 26.
    INDIVIDUALIZING THERAPY IN PATIENT SUBPOPULATIONS INFECTED WITH HCV WHO ARE COINFECTED WITH HIV, HAVE DECOMPENSATED CIRRHOSIS, OR HAVE UNDERGONE LIVER TRANSPLANTATION
    19:15
  19. 27.
    INDIVIDUALIZING THERAPY IN PATIENT SUBPOPULATIONS INFECTED WITH HCV WHO ARE COINFECTED WITH HIV, HAVE DECOMPENSATED CIRRHOSIS, OR HAVE UNDERGONE LIVER TRANSPLANTATION
    18:40
  20. 28.
    INDIVIDUALIZING THERAPY IN PATIENT SUBPOPULATIONS INFECTED WITH HCV WHO ARE COINFECTED WITH HIV, HAVE DECOMPENSATED CIRRHOSIS, OR HAVE UNDERGONE LIVER TRANSPLANTATION
    14:54
  21. 29.
    INDIVIDUALIZING THERAPY IN PATIENT SUBPOPULATIONS INFECTED WITH HCV WHO HAVE GENOTYPE 3, CIRRHOSIS, ARE INTERFERON-INELIGIBLE/INTOLERANT, OR HAVE FAILED PREVIOUS THERAPY
    17:42
  22. 30.
    INDIVIDUALIZING THERAPY IN PATIENT SUBPOPULATIONS INFECTED WITH HCV WHO HAVE GENOTYPE 3, CIRRHOSIS, ARE INTERFERON-INELIGIBLE/INTOLERANT, OR HAVE FAILED PREVIOUS THERAPY
    18:11
  23. 31.
    Highlights from the 2014 EASL Meeting
    36:40
  24. 32.
    HCV Screening and Natural History
    33:36
  25. 33.
    Susanna Naggie, MD Discussed HBV and HCV Coverage at AASLD
    41:50
  26. 34.
    Cure of Hepatitis B: Is it Achievable?
    36:05
  27. 35.
    The Role of Prediction Models: Best practices in Identifying Cirrhosis and HCC in Patients Infected with HBV
    29:46
  28. 36.
    European Association for the Study of the Liver HCV Update
    37:06
  29. 37.
    Hepatitis C and Host Genetics
    35:22
  30. 38.
    Reactivation of Hepatitis B Virus Infection
    37:04
  31. 39.
    HCV/HIV Coinfection
    36:30
  32. 40.
    Occult Hepatitis B Virus Infection
    33:56
  33. 41.
    Dr. Tram T. Tran will cover issues related to Hepatitis B and Pregnancy
    35:26

Listen to eViralHepatitis Review now.

Listen to eViralHepatitis Review in full in the Spotify app